Bronchoscopes Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Reusable Bronchoscopes(Rigid, Flexible), Single use), By End-use (Hospitals, Outpatient Facilities), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts

Bronchoscopes Market Summary

The global bronchoscopes market size was valued at USD 1.0 billion in 2025 and is projected to grow from USD 1.1 billion in 2026 to USD 2.3 billion by 2033, at a CAGR of 10.9% from 2026 to 2033. North America held the largest global share of 38.8% in 2025. The rising incidences of respiratory disorders and growing awareness about early diagnosis are driving demand for bronchoscopes.

Bronchoscopes are primarily used for the assessment and management of multiple respiratory and airway diseases. Conditions such as blockages, chronic obstructive pulmonary disease (COPD), bronchopulmonary hemorrhage, tumors, airway stenosis, and inflammatory conditions can be detected and diagnosed through these devices.

Market Dynamics

Market Concentration & Characteristics

The chart below illustrates the relationship between industry concentration, characteristics, and participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, level of partnerships & collaboration activities, degree of innovation, impact of regulations, and regional expansion. The bronchoscopes market is fragmented. The degree of innovation is high, and the level of merger and acquisition activities is moderate. The impact of regulations on industry and the regional expansion of industry is high.

The global bronchoscope market is characterized by a high degree of innovation, owing to rising investments, growing research activities, and the launch of new educational programs to enhance healthcare infrastructure and advance research in this field. For instance, in January 2026, FUJIFILM Healthcare Europe launched the EB-710US balloonless ultrasonic bronchoscope to enhance lung cancer detection and staging during EBUS-TBNA procedures. The bronchoscope is equipped with a compact high-performance ultrasonic transducer and CMOS imaging sensor designed to enhance ultrasound visualization and endoscopic observation during EBUS-guided procedures.

The bronchoscope industry is characterized by moderate merger and acquisition activity. Market players, such as Ambu A/S, Olympus, Boston Scientific Corporation, Fujifilm Holdings Corporation, and Karl Storz GmbH & Co., KG, are involved in mergers and acquisitions. Through M&A activity, these companies expand their geographic reach and enter new territories. For instance, in July 2024, Mary Washington Hospital (MWH), a hospital in Virginia, acquired the ion robotic bronchoscope system for the early detection of lung cancer through a bronchoscopy.

Regulations play an essential role in shaping the global market and ensuring the efficacy, safety, and quality of implants available to patients. For instance, the Medical Devices Bureau of the Therapeutic Products Directorate (TPD) regulates medical devices, including endoscopes (bronchoscopes). In addition, the Public Health Agency of Canada (PHAC) creates national guidelines for preventing and controlling infections. These guidelines are based on evidence and are meant to support the efforts of provincial & territorial governments in monitoring, preventing, and controlling healthcare-associated infections.

Several market players are expanding their businesses by launching new products to strengthen their market positions and expand their product portfolios. For instance, in September 2025, Olympus Corporation launched its BF-UCP190F endobronchial ultrasound (EBUS) bronchoscope across the EMEA region to strengthen its pulmonary diagnostics and lung cancer staging portfolio.

Technology Trend Analysis

Technology trends in bronchoscopes are rapidly evolving, driven by the need for higher diagnostic accuracy, minimally invasive procedures, and improved workflow efficiency. Innovations such as robotic-assisted navigation, single-use bronchoscopes, advanced imaging integration, and AI-enabled diagnostics are transforming bronchoscopy from a conventional visualization tool into a high-precision, multi-modal diagnostic and therapeutic platform. These advancements are particularly important for early detection of peripheral lung lesions, improving patient safety, and addressing operational challenges such as infection control and procedure efficiency.

Table 2 Key technology trends in bronchoscopes

Case Study: Use of Advanced Bronchoscopy in Diagnosing Interstitial Lung Disease

Patient Profile:

A 69-year-old non-smoking female with a prior diagnosis of Systemic Sclerosis (scleroderma) presented with worsening respiratory symptoms, including persistent dry cough and progressive dyspnea over two months. Clinical examination revealed bilateral crackles, while imaging (chest X-ray and HRCT) indicated a peripheral interstitial lung pattern, particularly in the lower lobes.

Clinical Objective:

To establish a definitive diagnosis of suspected interstitial lung involvement, transbronchial pulmonary cryobiopsy was planned to obtain high-quality lung tissue samples.

Procedure Overview:

The procedure was conducted in a dedicated bronchoscopy suite under general anesthesia using a laryngeal mask airway. A flexible bronchoscope, Ambu aScope 5 Broncho HD, was utilized for airway visualization and guidance. Local anesthesia was administered, and an occlusion balloon was placed to control potential bleeding. A flexible cryoprobe was advanced through the bronchoscope to the target segment in the lower right lobe, and multiple biopsy samples were obtained using controlled freezing cycles. The bronchoscope was reinserted post-sampling to confirm airway stability and absence of complications. A total of four cryobiopsies were successfully performed.

Results & Diagnosis:

Histopathological analysis revealed fibrosis patterns consistent with non-specific interstitial pneumonia (NSIP), confirming a diagnosis of interstitial lung disease associated with systemic sclerosis (ILD-SS).

Technology & Device Insights:

The procedure demonstrated the importance of advanced bronchoscopy technologies in complex diagnostic interventions. Key performance advantages observed with the bronchoscope included:

• Stable angulation without deflection during cryoprobe insertion

• High-definition visualization, ensuring clear and precise sampling

• Enhanced maneuverability, supported by a rotation ring design for accessing difficult lung segments

• Lightweight structure, enabling better control during challenging upper lobe procedures

Clinical & Market Implications:

This case highlights the growing role of minimally invasive, high precision bronchoscopy techniques such as transbronchial cryobiopsy in diagnosing complex pulmonary conditions. The ability of advanced bronchoscopes to maintain stability, provide superior visualization, and improve procedural efficiency underscores their value in modern pulmonary care. Such technological advancements are driving increased adoption of single-use and high-performance bronchoscopes, particularly specialized models, supporting market growth by improving clinical outcomes and operational efficiency.

Product Insights

The reusable bronchoscopes segment dominated the market, accounting for the largest revenue share of 76.5% in 2025, as these systems are widely utilized across pulmonology, thoracic surgery, critical care, and interventional bronchoscopy for applications including airway examination, bronchoalveolar lavage (BAL), tissue biopsy, secretion management, foreign body removal, and tumor intervention. The reusable bronchoscopes market is primarily driven by the increasing prevalence of respiratory diseases, including lung cancer, COPD, asthma, and pulmonary infections, as well as the growing adoption of minimally invasive pulmonary diagnostics.

The single use / disposable bronchoscopes segment is anticipated to grow at the fastest CAGR during the forecast period. The segment witnessed accelerated adoption following heightened awareness regarding cross-contamination risks and hospital-acquired infections, particularly in critical care environments. Healthcare providers are increasingly prioritizing single-use bronchoscopy platforms to reduce the risk of pathogen transmission associated with variability in reusable endoscope reprocessing.

End Use Insights

The hospitals segment dominated the bronchoscopes industry, accounting for the largest share of 57.3% in 2025. Hospitals represent the largest and most technologically advanced end-use segment for bronchoscopy systems, serving as the primary centers for complex pulmonary diagnosis, therapeutic airway intervention, and critical respiratory care. Bronchoscopes within hospital settings are extensively utilized across pulmonology, thoracic surgery, intensive care, anesthesiology, oncology, and emergency medicine departments for procedures including airway inspection, bronchoalveolar lavage (BAL), transbronchial biopsy, secretion management, tumor debulking, airway stenting, and management of complex respiratory disorders such as lung cancer and central airway obstruction.

The outpatient facilities segment is expected to grow at the fastest CAGR from 2026 to 2033. The segment is witnessing steady growth as healthcare systems increasingly shift non-emergency pulmonary diagnostics out of inpatient settings to reduce hospital burden and optimize resource utilization. Rising demand for minimally invasive respiratory diagnostics, growing emphasis on value-based care delivery, and increasing patient preference for same-day procedures are accelerating the migration of bronchoscopy procedures toward outpatient settings.

Regional Insights

The North America bronchoscopes market dominated with 38.8% share in 2025. The growing geriatric population in the U.S. and Canada, which is more susceptible to chronic respiratory conditions, is further contributing to procedure volumes. According to estimates from the American Cancer Society data published in January 2026, approximately 229,410 new lung cancer cases are expected in the U.S. in 2026, including around 110,910 cases in men and 118,500 cases in women. Moreover, Healthcare facilities across the U.S. are increasingly shifting toward disposable bronchoscopes to reduce infection risks, eliminate reprocessing requirements, and improve workflow efficiency in critical care settings.

U.S. Bronchoscopes Market Trends

The U.S. bronchoscopes industry dominated North America in 2025, driven by the increasing prevalence of respiratory diseases such as lung cancer, COPD, asthma, pneumonia, and other pulmonary infections. As per the Asthma and Allergy Foundation of America report, asthma is one of the most common chronic respiratory diseases in the U.S., affecting nearly 28 million people, or approximately 8% of the population. Among adults, around 23 million individuals aged 18 years and older live with asthma, representing nearly 9 out of every 100 adults. In addition, the growing elderly population in the U.S., which is more susceptible to chronic respiratory disorders, is contributing significantly to the rising number of pulmonary interventions performed in hospitals and outpatient settings.

Europe Bronchoscopes Market Trends

The Europe bronchoscopes industry’s growth is driven by the rising burden of respiratory diseases, increasing lung cancer screening programs, growing focus on infection prevention, and rapid technological advancements in bronchoscopy systems. According to the European Respiratory Society, chronic respiratory diseases affect more than 80 million people in the European Union, while lung cancer accounts for over 380,000 new cases annually. This growing disease burden has substantially increased the demand for diagnostic and therapeutic bronchoscopy procedures across hospitals and specialty pulmonary centers.

The Germany bronchoscopes market is expected to witness significant growth over the forecast period. Germany’s nationwide lung cancer screening program is expected to significantly drive demand for bronchoscopes by increasing the detection of suspicious pulmonary nodules and early-stage lung cancer cases that require bronchoscopic diagnosis and biopsy procedures. The program, officially launched in April 2026, provides insurance-covered low-dose CT (LDCT) screening for high-risk individuals aged 50-75 with a significant smoking history. As more patients undergo screening, hospitals and specialized lung cancer centers are expected to experience a substantial rise in follow-up diagnostic procedures, particularly bronchoscopy-based tissue sampling and lesion evaluation.

The bronchoscopes market in France is expected to witness significant growth over the forecast period. Growing technological collaborations and advancements in robotic bronchoscopy are significantly driving bronchoscope demand in France by improving early lung cancer diagnosis, enhancing procedural accuracy, and expanding access to minimally invasive pulmonary interventions. For instance, the partnership between FUJIFILM Healthcare Europe and Lys Medical announced in February 2026 is particularly important for the France market as the company’s announced commercialization of the Iriscope platform in France as part of Fujifilm’s expanding pulmonology portfolio.

Asia Pacific Bronchoscopes Market Trends

Asia Pacific is expected to grow at the fastest CAGR over the forecast period, owing to the improved healthcare infrastructure, the presence of a less stringent regulatory framework, and economic development attracting foreign investments. Growth in the region is expected to be driven by favorable initiatives undertaken by private players, such as training healthcare professionals and increasing research & development investments to develop advanced endoscopes. Companies such as Olympus Corporation, FUJIFILM Holdings Corporation, Ambu A/S, and PENTAX Medical are expanding their bronchoscopy portfolios in Asia Pacific with high-definition imaging systems and single-use bronchoscope solutions.

China bronchoscopes market is expected to witness significant growth over the forecast period. The growth is driven primarily by the rising burden of lung diseases, increasing adoption of minimally invasive pulmonary procedures, rapid technological innovation, and strong investments in healthcare infrastructure. China’s medtech companies are heavily investing in robotic bronchoscopy systems capable of improving navigation accuracy for peripheral lung lesions and enabling minimally invasive biopsies. For instance, in 2025, Edge Medical received NMPA approval for its robotic bronchoscopy platform designed for diagnostic and therapeutic pulmonary procedures, highlighting China’s accelerating domestic innovation ecosystem in respiratory endoscopy.

The bronchoscopes market in Japan is expected to witness significant growth over the forecast period. The market growth is strongly driven by the country’s rapidly aging population, rising incidence of lung cancer and chronic respiratory diseases, increasing preference for minimally invasive diagnostic procedures, and continuous technological innovation by domestic manufacturers such as Olympus Corporation, FUJIFILM Holdings Corporation, and HOYA Corporation. For instance, in May 2024, Olympus Corporation launched two new bronchoscopes compatible with its EVIS X1 endoscopy platform, offering enhanced imaging and smaller outer diameters for improved pulmonary diagnostics.

Latin America Bronchoscopes Market Trends

The Latin America bronchoscopes industry’s growth is driven by the rising prevalence of respiratory diseases, including chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis, and respiratory infections, across the region. The increasing demand for minimally invasive diagnostic and therapeutic procedures is accelerating the adoption of flexible and video bronchoscopes in hospitals and specialty pulmonary centers. Expanding healthcare infrastructure, growing investments in endoscopy services, and improving access to advanced respiratory care technologies are further supporting market growth.

Middle East & Africa Bronchoscopes Market Trends

The Middle East & Africa bronchoscopes industry is expected to witness significant growth over the forecast period. Rising healthcare investments, expanding hospital infrastructure, and growing adoption of minimally invasive pulmonary diagnostic procedures are supporting demand for advanced bronchoscopy systems. Governments and healthcare providers are increasingly focusing on improving respiratory care services and expanding access to specialized diagnostic technologies. In addition, rising smoking prevalence, increasing exposure to air pollution, and growing incidence of infectious respiratory diseases are accelerating the need for bronchoscopy procedures in hospitals and specialty care centers across the region.

Key Bronchoscopes Company Insights

Some of the key companies in the bronchoscopes market include Olympus Corporation, Ambu A/S, FUJIFILM Holdings Corporation, Boston Scientific Corporation, Richard Wolf GmbH, and Broncus Medical, Inc.

• Ambu A/S specializes in developing, producing, and delivering innovative healthcare solutions in the fields of single-use endoscopy, anesthesia, and patient monitoring. The company’s endoscopy solutions portfolio includes high-performance single-use flexible endoscopes such as the Ambu aScope 4 Broncho. This product line offers sterile, convenient bronchoscopes for a wide range of medical procedures.

Key Bronchoscopes Companies

The following key companies have been profiled for this study on the bronchoscopes market.

• Olympus Corporation

• Ambu Inc.

• Teleflex Incorporated.

• KARL STORZ SE & Co. KG

• FUJIFILM Holdings Corporation

• Boston Scientific Corporation

• Richard Wolf GmbH

• PENTAX Medical (a division of HOYA Group)

• Cook

• Broncus Medical, Inc. (Broncus Holding Corporation is the parent company)

• Johnson & Johnson

• Praxis Medical.

Competitive Benchmarking

Recent Developments

• In March 2026, KARL STORZ received FDA clearance for its FIVE S 6.5 single-use bronchoscope, designed for critical care and airway management procedures. The device features a large 3.0 mm working channel for powerful secretion clearance, enhanced maneuverability, and integration with the C-MAC visualization platform for high-quality imaging and workflow efficiency.

“The FIVE S 6.5 single-use bronchoscope delivers precise articulation, powerful secretion clearance, and sharp visualization. Whether performing bronchoscopy, lavage, or airway inspection, the FIVE S 6.5 provides the reliability you need when every second counts.”

- Executive Director, Sales & Marketing, Airway and Emergency Medicine at KARL STORZ North America.

• In February 2026, FUJIFILM Healthcare Europe GmbH announced a distribution partnership with Lys Medical, manufacturer of the Iriscope platform, to strengthen its pulmonology and bronchoscopy portfolio across the European market. The partnership aims to expand access to advanced bronchoscopy technologies and support pulmonologists with enhanced tools for peripheral lung navigation and minimally invasive lung cancer diagnosis.

“We are delighted with this strategic partnership. By combining the strengths of Fujifilm Healthcare Europe and Lys Medical, we deliver a cohesive and comprehensive solution for peripheral bronchoscopy. Our goal is clear: to improve diagnostic reliability for peripheral pulmonary lesions and enhance patient care.”

- Benjamin Mertens, CEO, Lys Medical.

• In February 2026, Olympus Corporation received FDA clearance for pediatric use of two H-SteriScope single-use video flexible bronchoscopes distributed through its respiratory portfolio. The Zero BCV1-02 model is indicated for pediatric patients aged 6 months to 6 years, while the Slim BCV1-C2 model is indicated for children aged 6 years and older. The devices are designed to support safer and more precise pediatric bronchoscopy procedures while expanding Olympus’ single-use respiratory endoscopy portfolio.

“Olympus is very pleased to announce the pediatric indication for the Zero and Slim H-SteriScope bronchoscopes. Patient focus is at the core of everything we do as Olympus strives to provide physicians with the tools they need to help improve patient outcomes. Olympus’ bronchoscopy portfolio offers the right scope for the right patient in the right situation.”

-Senior Vice President and General Manager, Respiratory

• In March 2025, Johnson & Johnson MedTech received FDA 510(k) clearance for MONARCH QUEST, an enhanced robotic-assisted bronchoscopy platform featuring AI-powered navigation algorithms and integration with GE HealthCare’s OEC 3D imaging system. The upgraded system is designed to improve navigation accuracy, target peripheral lung nodules, and workflow efficiency during minimally invasive lung biopsy procedures.

“Our goal with the MONARCH Platform is to change the treatment paradigm for diseases such as lung cancer, where significant unmet needs remain. MONARCH QUEST demonstrates our commitment to delivering meaningful innovation that helps clinicians advance the standard of care for their patients.”

-President, MONARCH, Johnson & Johnson MedTech.

Bronchoscopes Market Report Scope

Global Bronchoscopes Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global bronchoscopes market report based on product, end use, and region:

• Product Outlook (Volume Install Base (in Thousand Units); Annual Equipment Sales Volume (in Absolute Numbers); Revenue (in USD Million/Billion), 2021 - 2033)

  • Reusable Bronchoscopes

    • Rigid Bronchoscopes

      • Standard Rigid Bronchoscopes

      • Interventional Rigid Bronchoscopes

    • Flexible Bronchoscopes

      • Standard Flexible Bronchoscopes

      • EBUS Bronchoscopes (Endobronchial Ultrasound)

      • Therapeutic / Interventional Bronchoscopes

      • Ultra-Thin / Pediatric Bronchoscopes

  • Single use / Disposable Bronchoscopes

• End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Hospitals

  • Outpatient Facilities

• Regional Outlook (Volume Install Base (in Thousand Units); Annual Equipment Sales Volume (in Absolute Numbers); Revenue (in USD Million/Billion), 2021 - 2033)

  • North America

    • U.S.

    • Mexico

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Thailand

    • Australia

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait